Trinity Biotech PLC Files 6-K Report
Ticker: TRIB · Form: 6-K · Filed: Nov 15, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Nov 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Trinity Biotech PLC filed a standard 6-K, confirming their reporting status and Irish HQ.
AI Summary
Trinity Biotech PLC filed a Form 6-K on November 15, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its report under the 1934 Securities Exchange Act and will file annual reports under Form 20-F. The principal executive offices are located in Bray, Co. Wicklow, Ireland.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing updates on their reporting status and administrative details to the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- IDA Business Park Bray, Co. Wicklow, Ireland (location) — Principal Executive Office Address
- 1934 Act (regulation) — Securities Exchange Act
- Form 20-F (form) — Annual Report Filing
- Form 6-K (form) — Report Type
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
What is Trinity Biotech PLC's primary reporting form for annual reports?
Trinity Biotech PLC indicates it files annual reports under cover of Form 20-F.
Where are Trinity Biotech PLC's principal executive offices located?
Trinity Biotech PLC's principal executive offices are located at IDA Business Park, Bray, Co. Wicklow, Ireland.
What is the filing date of this Form 6-K?
This Form 6-K was filed on November 15, 2024.
Under which act is this Form 6-K filed?
This Form 6-K is filed under the 1934 Act (Securities Exchange Act of 1934).
Filing Stats: 309 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-11-15 13:22:01
Filing Documents
- zk2432323.htm (6-K) — 14KB
- exhibit_99-1.htm (EX-99.1) — 449KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-003735.txt ( ) — 589KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ Louise Tallon Louise Tallon Chief Financial Officer Date: November 15, 2024